Annual Operating Expenses
$15.89 M
+$4.47 M+39.13%
December 31, 2023
Summary
- As of February 12, 2025, NRBO annual total operating expenses is $15.89 million, with the most recent change of +$4.47 million (+39.13%) on December 31, 2023.
- During the last 3 years, NRBO annual operating expenses has fallen by -$13.83 million (-46.54%).
- NRBO annual operating expenses is now -52.04% below its all-time high of $33.12 million, reached on December 31, 2017.
Performance
NRBO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$6.26 M
-$3.83 M-37.93%
September 30, 2024
Summary
- As of February 12, 2025, NRBO quarterly total operating expenses is $6.26 million, with the most recent change of -$3.83 million (-37.93%) on September 30, 2024.
- Over the past year, NRBO quarterly operating expenses has increased by +$592.00 thousand (+10.45%).
- NRBO quarterly operating expenses is now -67.93% below its all-time high of $19.52 million, reached on December 31, 2020.
Performance
NRBO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NRBO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.1% | +10.4% |
| 3 y3 years | -46.5% | +80.7% |
| 5 y5 years | +2.6% | +71.7% |
NRBO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +39.1% | -37.9% | +181.9% |
| 5 y | 5-year | -46.5% | +39.1% | -67.9% | +181.9% |
| alltime | all time | -52.0% | +5872.2% | -67.9% | +255.8% |
NeuroBo Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.26 M(-37.9%) |
| Jun 2024 | - | $10.08 M(+46.5%) |
| Mar 2024 | - | $6.88 M(+21.4%) |
| Dec 2023 | $15.89 M(+39.1%) | $5.67 M(+45.6%) |
| Sep 2023 | - | $3.89 M(+2.3%) |
| Jun 2023 | - | $3.81 M(+51.0%) |
| Mar 2023 | - | $2.52 M(+13.5%) |
| Dec 2022 | $11.42 M(-25.4%) | $2.22 M(-28.5%) |
| Sep 2022 | - | $3.10 M(-3.6%) |
| Jun 2022 | - | $3.22 M(+12.0%) |
| Mar 2022 | - | $2.88 M(-37.2%) |
| Dec 2021 | $15.30 M(-48.5%) | $4.58 M(+32.2%) |
| Sep 2021 | - | $3.46 M(-11.8%) |
| Jun 2021 | - | $3.93 M(+17.9%) |
| Mar 2021 | - | $3.33 M(-82.9%) |
| Dec 2020 | $29.72 M(+47.3%) | $19.52 M(+537.7%) |
| Sep 2020 | - | $3.06 M(+27.9%) |
| Jun 2020 | - | $2.39 M(-49.6%) |
| Mar 2020 | - | $4.75 M(-61.1%) |
| Dec 2019 | $20.18 M | $12.19 M(+234.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $3.65 M(+93.2%) |
| Jun 2019 | - | $1.89 M(-23.0%) |
| Mar 2019 | - | $2.45 M(-161.0%) |
| Dec 2018 | $15.49 M(-53.2%) | -$4.02 M(-168.0%) |
| Sep 2018 | - | $5.91 M(-9.6%) |
| Jun 2018 | - | $6.53 M(-7.5%) |
| Mar 2018 | - | $7.06 M(+7.6%) |
| Dec 2017 | $33.12 M(+125.4%) | $6.57 M(-23.1%) |
| Sep 2017 | - | $8.54 M(-18.8%) |
| Jun 2017 | - | $10.52 M(+40.1%) |
| Mar 2017 | - | $7.50 M(+3.8%) |
| Dec 2016 | $14.70 M(+105.0%) | $7.23 M(+112.5%) |
| Sep 2016 | - | $3.40 M(+84.9%) |
| Jun 2016 | - | $1.84 M(-17.3%) |
| Mar 2016 | - | $2.23 M(-11.4%) |
| Dec 2015 | $7.17 M(+2594.7%) | $2.51 M(+6.1%) |
| Sep 2015 | - | $2.37 M(+47.0%) |
| Jun 2015 | - | $1.61 M(+1.3%) |
| Mar 2015 | - | $1.59 M |
| Dec 2014 | $266.00 K | - |
FAQ
- What is NeuroBo Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals annual operating expenses year-on-year change?
- What is NeuroBo Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for NeuroBo Pharmaceuticals?
- What is NeuroBo Pharmaceuticals quarterly operating expenses year-on-year change?
What is NeuroBo Pharmaceuticals annual total operating expenses?
The current annual operating expenses of NRBO is $15.89 M
What is the all time high annual operating expenses for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high annual total operating expenses is $33.12 M
What is NeuroBo Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, NRBO annual total operating expenses has changed by +$4.47 M (+39.13%)
What is NeuroBo Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of NRBO is $6.26 M
What is the all time high quarterly operating expenses for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high quarterly total operating expenses is $19.52 M
What is NeuroBo Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, NRBO quarterly total operating expenses has changed by +$592.00 K (+10.45%)